High-sensitivity C-reactive protein, often written as hs-CRP, is a blood test that measures very small amounts of C-reactive protein, a protein that rises when the body is inflamed. The “high-sensitivity” part means the test can detect low levels of inflammation that a standard CRP test may not measure well. In everyday care, hs-CRP is most often used as a cardiovascular risk marker, not as a stand-alone diagnosis.
A higher hs-CRP result can reflect low-grade inflammation linked with artery plaque, metabolic health problems, smoking, obesity, chronic inflammatory disease, or a recent infection. A low result usually suggests a lower inflammatory burden at the time of testing. Because hs-CRP is nonspecific, the number has to be interpreted with symptoms, medical history, cholesterol markers, blood pressure, glucose status, and other risk factors. One result can be helpful, but a repeat test is often more meaningful when the first result is unexpectedly high.
- hs-CRP measures low-grade inflammation and is commonly used to help estimate cardiovascular risk.
- Less than 1 mg/L is usually considered lower cardiovascular risk, 1–3 mg/L average risk, and above 3 mg/L higher risk.
- An hs-CRP of 2 mg/L or higher may count as a cardiovascular risk-enhancing factor in some prevention decisions.
- Results above 10 mg/L often suggest a recent infection, injury, or active inflammatory condition and are usually repeated after recovery.
- Fasting is usually not required, but fasting may be needed if hs-CRP is drawn with cholesterol or glucose tests.
- hs-CRP does not show where inflammation is coming from, so follow-up depends on symptoms and the rest of the lab picture.
Table of Contents
- What the hs-CRP Test Measures
- hs-CRP vs Standard CRP
- Normal Range and Cardiovascular Risk Levels
- High hs-CRP Causes
- Low hs-CRP Meaning
- Testing, Preparation, and Timing
- How to Interpret hs-CRP Results With Other Markers
- How hs-CRP May Improve Over Time
What the hs-CRP Test Measures
The hs-CRP test measures C-reactive protein in the blood at very low concentrations. C-reactive protein is made mainly by the liver in response to inflammatory signals, especially a messenger protein called interleukin-6. When tissues are irritated, infected, injured, or chronically stressed, CRP can rise.
The test result is usually reported in milligrams per liter, written as mg/L. A result of 0.7 mg/L, for example, means there is less measurable inflammation than a result of 4.5 mg/L. That does not automatically mean the person with 4.5 mg/L has heart disease. It means the blood sample showed more inflammatory activity at the time it was drawn.
Inflammation is part of normal healing. It helps the body respond to injury and infection. The concern with hs-CRP is persistent, low-grade inflammation that continues in the background. In artery disease, inflammation can contribute to the development, growth, and instability of atherosclerotic plaque. This is one reason hs-CRP is often discussed alongside cholesterol markers.
hs-CRP is not a cholesterol test. It does not measure LDL cholesterol, HDL cholesterol, triglycerides, plaque, or artery narrowing. A person can have excellent cholesterol numbers and still have an elevated hs-CRP. Another person can have high LDL cholesterol and a low hs-CRP. These markers describe different parts of cardiovascular risk.
For this reason, hs-CRP is most useful when it adds context to a broader risk assessment. A standard lipid panel shows the main cholesterol and triglyceride values. hs-CRP adds information about inflammation, which may help refine risk in selected people, especially when treatment decisions are uncertain.
hs-CRP vs Standard CRP
hs-CRP and standard CRP measure the same protein. The difference is the sensitivity of the assay and the clinical question being asked.
A standard CRP test is used when a clinician is looking for larger inflammatory changes. It may be ordered when infection, autoimmune disease, inflammatory bowel disease, tissue injury, or another active inflammatory process is suspected. Standard CRP is useful across a wide range of high values.
An hs-CRP test is designed to measure lower levels more precisely. This makes it better suited for cardiovascular risk assessment, where the relevant range is often between about 0.3 and 10 mg/L. In that lower range, small differences can be meaningful when interpreted with other risk factors.
| Feature | Standard CRP | hs-CRP |
|---|---|---|
| Measures | C-reactive protein | C-reactive protein |
| Main use | General inflammation, infection, autoimmune activity, tissue injury | Low-grade inflammation and cardiovascular risk assessment |
| Best range | Moderate to very high CRP levels | Low CRP levels, often below 10 mg/L |
| Common question | “Is there active inflammation?” | “Is low-grade inflammation adding to heart risk?” |
A common mistake is treating hs-CRP as a more advanced version of CRP for every situation. It is more sensitive at low levels, but that does not make it more specific. It still cannot identify the source of inflammation. If hs-CRP is high, the next step is not to assume artery inflammation. The next step is to ask whether there was a recent cold, dental infection, injury, vaccination, flare of arthritis, intense exercise, or another obvious reason.
Another useful comparison is the ESR blood test, which also reflects inflammation but behaves differently. ESR can rise with inflammation, anemia, age, pregnancy, and changes in blood proteins. hs-CRP usually changes faster than ESR and is often preferred when clinicians want a more responsive inflammatory marker.
Normal Range and Cardiovascular Risk Levels
hs-CRP ranges are not “normal” in the same way that sodium or potassium ranges are normal. They are often interpreted as cardiovascular risk categories. The most widely used categories are less than 1 mg/L, 1 to 3 mg/L, and greater than 3 mg/L.
| hs-CRP result | Common interpretation | Typical next step |
|---|---|---|
| Less than 1 mg/L | Lower inflammatory cardiovascular risk | Review overall risk, not usually concerning by itself |
| 1 to 3 mg/L | Average or intermediate inflammatory risk | Interpret with cholesterol, blood pressure, glucose, smoking status, and family history |
| Above 3 mg/L | Higher inflammatory risk | Look for temporary causes and consider repeat testing when well |
| Above 10 mg/L | Often too high for routine cardiovascular interpretation | Evaluate for infection, injury, inflammatory disease, or another active cause; repeat later |
Some cardiovascular prevention guidelines also use 2 mg/L as an important threshold. An hs-CRP of 2 mg/L or higher can be considered a risk-enhancing factor, especially in people whose estimated 10-year cardiovascular risk is borderline or intermediate. In plain language, this means the result may push a prevention conversation toward more aggressive lifestyle changes, closer risk review, or medication discussion when the decision is otherwise uncertain.
The number should not be used in isolation. A 45-year-old nonsmoker with excellent blood pressure, no diabetes, low LDL cholesterol, and hs-CRP of 2.2 mg/L does not have the same risk as a 65-year-old smoker with high blood pressure, high ApoB, and hs-CRP of 2.2 mg/L. The same hs-CRP value carries different meaning depending on the whole clinical picture.
Units matter. hs-CRP is usually reported in mg/L. Some labs report CRP in mg/dL. To convert mg/dL to mg/L, multiply by 10. A CRP of 0.3 mg/dL equals 3 mg/L. Misreading units can make a result look ten times higher or lower than it really is.
For cardiovascular risk, repeated values are often more useful than one value. If one result is high during a mild respiratory infection, it may fall back to a lower range a few weeks later. If two separate hs-CRP tests remain elevated when a person feels well, the result is more likely to reflect persistent low-grade inflammation.
High hs-CRP Causes
A high hs-CRP result means inflammation is present, but it does not identify the cause. The most helpful first question is whether the elevation is temporary or persistent.
Temporary elevations are common. hs-CRP can rise after a cold, flu, COVID-19, urinary tract infection, dental infection, surgery, injury, muscle strain, intense endurance exercise, vaccination, or a flare of a known inflammatory condition. In these situations, the result may not reflect usual cardiovascular inflammatory risk.
Persistent elevations are more important for long-term risk assessment. Common contributors include excess visceral body fat, insulin resistance, smoking, poor sleep, untreated gum disease, chronic inflammatory disorders, fatty liver disease, kidney disease, and some autoimmune conditions. These factors can keep inflammatory signaling active even when a person does not feel sick.
Metabolic health is one of the most common reasons hs-CRP stays mildly elevated. Abdominal weight gain, high triglycerides, low HDL cholesterol, high fasting glucose, high insulin, and high blood pressure often travel together. A metabolic syndrome blood test panel can give better context when hs-CRP is high and the person also has weight gain, prediabetes, or high triglycerides.
Cholesterol particle burden also matters. hs-CRP reflects inflammation, while LDL cholesterol and ApoB reflect the number or amount of atherogenic particles that can enter the artery wall. When both inflammation and atherogenic particle burden are high, cardiovascular risk may be more concerning than either marker alone. This is why clinicians may compare hs-CRP with ApoB testing, LDL cholesterol, non-HDL cholesterol, or LDL particle number in people with complex risk profiles.
High hs-CRP can also appear in people with autoimmune and inflammatory diseases such as rheumatoid arthritis, lupus, psoriasis, inflammatory bowel disease, and chronic infections. In those cases, hs-CRP may partly reflect disease activity. The cardiovascular meaning does not disappear, but the result should be interpreted through the condition that is already known to raise inflammation.
Very high results deserve a different approach. When hs-CRP is above 10 mg/L, the result often points to an acute or active inflammatory problem rather than subtle cardiovascular risk. A clinician may repeat the test after two or more weeks, especially after symptoms have resolved. If the result stays above 10 mg/L without an obvious cause, further evaluation is usually appropriate.
Low hs-CRP Meaning
A low hs-CRP result usually means there is little measurable systemic inflammation at the time of the blood draw. For cardiovascular risk, a result below 1 mg/L is generally considered favorable. It suggests that inflammation is less likely to be a major risk amplifier.
Low hs-CRP does not rule out heart disease. A person can still have high LDL cholesterol, high ApoB, high lipoprotein(a), high blood pressure, diabetes, a strong family history, or established plaque with a low hs-CRP. Inflammation is one part of cardiovascular biology, not the entire story.
Low hs-CRP also does not rule out every inflammatory condition. Some diseases flare in specific tissues without causing a large blood CRP response. Some people produce less CRP than others for genetic or biological reasons. Medications such as statins and certain anti-inflammatory drugs may also lower hs-CRP.
When hs-CRP is low and other risk markers are also favorable, the result can be reassuring. For example, low hs-CRP combined with healthy blood pressure, normal glucose, low triglycerides, and low ApoB suggests a lower-risk pattern. But if LDL cholesterol or Lp(a) is high, a low hs-CRP should not be used as a reason to ignore those markers.
The most useful interpretation is balanced: low hs-CRP is a good sign for inflammatory burden, but it is not a “clean bill of health.” It should sit beside the rest of the cardiovascular risk profile.
Testing, Preparation, and Timing
The hs-CRP test is a routine blood draw, usually from a vein in the arm. It does not require special preparation by itself. You can usually eat and drink normally unless other tests are being done at the same time.
Fasting may be requested if the blood draw includes cholesterol, triglycerides, fasting glucose, insulin, or other metabolic tests. Many lipid panels can now be done without fasting, but fasting is still useful in selected situations, especially when triglycerides or insulin resistance are being evaluated. If hs-CRP is being paired with a fasting insulin test, follow the fasting instructions given by the ordering clinician or lab.
Timing affects hs-CRP more than many people realize. The best time to test for cardiovascular risk is when you feel well and have not recently had an infection, injury, surgery, or inflammatory flare. Testing during a cold or after a hard race can make hs-CRP look higher than your usual baseline.
Reasonable timing rules include:
- Wait until acute illness has resolved before testing for cardiovascular risk.
- Avoid testing right after surgery, trauma, or a major dental infection unless the clinician is intentionally monitoring inflammation.
- Consider avoiding unusually intense exercise for 24 to 48 hours before the draw.
- Tell your clinician about recent vaccines, infections, injuries, or medication changes.
- Do not stop prescribed medication just to “see the real number” unless your clinician tells you to.
When an hs-CRP result is unexpectedly high, repeating it is often the cleanest next step. Many clinicians repeat hs-CRP about two weeks later or after the temporary trigger has passed. If both results are similar and the person feels well, the average may better represent baseline inflammatory status.
The test is usually ordered in adults, especially when cardiovascular risk is being refined. It is less useful as a broad screening test in children or in adults with obvious acute illness, because the result is likely to reflect the current illness rather than long-term cardiovascular risk.
How to Interpret hs-CRP Results With Other Markers
hs-CRP becomes more useful when it is interpreted with other markers rather than as a single number. Cardiovascular risk comes from several overlapping pathways: atherogenic particles, blood pressure, glucose metabolism, inflammation, clotting tendency, smoking exposure, kidney function, genetics, age, and family history.
Start with the basics. LDL cholesterol, non-HDL cholesterol, HDL cholesterol, and triglycerides show the standard lipid pattern. LDL cholesterol remains central because LDL particles are a main driver of atherosclerosis. If hs-CRP is high but LDL cholesterol targets have not been addressed, inflammation should not distract from proven cholesterol management.
ApoB can sharpen the picture because each atherogenic particle usually carries one ApoB protein. A person with normal LDL cholesterol but high ApoB may still have many atherogenic particles, especially if triglycerides are high or insulin resistance is present. In that setting, hs-CRP may add evidence that metabolic inflammation is part of the risk pattern.
Triglycerides and HDL cholesterol can point toward insulin resistance. High triglycerides, low HDL cholesterol, higher waist size, fatty liver, and elevated fasting insulin often overlap with hs-CRP elevations. The triglyceride/HDL ratio is sometimes used as a simple metabolic clue, although it does not replace formal diagnosis.
Glucose markers matter because diabetes and prediabetes raise cardiovascular risk. Fasting glucose, hemoglobin A1c, fasting insulin, and sometimes an oral glucose tolerance test can show whether blood sugar or insulin resistance is contributing. If hs-CRP is high in a person with prediabetes, weight gain, and high triglycerides, improving metabolic health is usually a central part of reducing risk.
Other inflammatory or tissue markers may also help. A complete blood count can show high white blood cells, anemia, or platelet changes. Ferritin can rise with inflammation as well as iron overload, so a high ferritin result may need careful interpretation. In some people, high ferritin and inflammation overlap, while in others the issue is excess iron storage.
Symptoms change the meaning of the result. Chest pain, shortness of breath, weakness on one side, sudden severe headache, fainting, or signs of serious infection should never be interpreted through hs-CRP alone. hs-CRP is not a heart attack rule-out test. Troponin, ECG findings, imaging, and urgent clinical evaluation are used when acute heart injury or stroke is possible.
How hs-CRP May Improve Over Time
Lowering hs-CRP starts with finding the likely driver. Because hs-CRP is a marker, not a disease, the best strategy depends on why it is elevated.
For many adults, the most effective steps are the same habits that reduce cardiovascular risk overall. Weight loss in people with excess visceral fat can lower inflammatory signaling. Regular physical activity improves insulin sensitivity, blood pressure, triglycerides, and inflammatory tone. A Mediterranean-style eating pattern, rich in vegetables, beans, lentils, whole grains, nuts, olive oil, fish, and minimally processed foods, is often a practical foundation.
Smoking cessation is one of the strongest inflammation-lowering steps. Tobacco smoke injures blood vessels, increases oxidative stress, and raises cardiovascular risk through several pathways. Quitting can improve inflammatory markers and risk over time, even if hs-CRP does not normalize immediately.
Sleep and dental health are often overlooked. Short sleep, untreated sleep apnea, chronic gum disease, and recurring dental infections can contribute to systemic inflammation. Someone with stubbornly elevated hs-CRP may need to look beyond diet and cholesterol numbers.
Medications may also change hs-CRP. Statins often reduce hs-CRP in addition to lowering LDL cholesterol. That does not mean statins are prescribed only to lower hs-CRP; their main cardiovascular role is reducing atherogenic cholesterol burden and events. In people with established cardiovascular disease and persistent inflammatory risk, clinicians may consider broader anti-inflammatory strategies, but that is individualized and should not be self-directed.
Supplements should be approached carefully. Fish oil, vitamin D, curcumin, and other supplements are often promoted for inflammation, but their effects vary, and they do not replace treating the cause. A supplement can also create a false sense of action while important issues such as smoking, blood pressure, diabetes, sleep apnea, or high ApoB remain untreated.
A useful follow-up plan is specific and measurable. If hs-CRP is mildly elevated, a clinician may repeat it after a period of recovery or lifestyle change, often along with lipids, glucose markers, blood pressure review, and weight or waist measurement. The aim is not to chase a perfect hs-CRP number. The aim is to reduce the conditions that keep inflammation and cardiovascular risk high.
References
- C-reactive protein and cardiovascular risk in the general population 2026 (Cohort Study)
- High-sensitivity C-reactive Protein in Atherosclerotic Cardiovascular Disease: To Measure or Not to Measure? 2025 (Review)
- High-Sensitivity C-Reactive Protein and Residual Inflammatory Risk in Cardiovascular Disease 2026 (Review)
- Inflammation and Cardiovascular Disease: 2025 ACC Expert Consensus Decision Pathway 2025 (Guideline)
- C-reactive protein test 2025 (Official Medical Page)
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease 2019 (Guideline)
Disclaimer
hs-CRP is a nonspecific inflammation marker and cannot diagnose heart disease, infection, autoimmune disease, or any other condition by itself. Results should be interpreted with symptoms, medical history, medications, and other cardiovascular and inflammatory markers. Seek urgent medical care for chest pain, trouble breathing, stroke symptoms, fainting, severe weakness, or signs of serious infection.
